KEY MESSAGES

Clinical presentation of monkeypox virus (MPV) may include painful mucosal lesions requiring supportive care and antivirals, such as Tecovirimat (TPOXX).
Testing capability has expanded to commercial reference labs but is available at the Illinois Department of Public Health lab for urgent testing due to severe clinical presentation, for those underinsured, and for cases associated with congregate settings.
The antiviral Tecovirimat (TPOXX) is available for use under Expanded Access-Investigational New Drug; this process has been simplified. Clinicians may request TPOXX therapy at https://redcap.link//mpxtreatment.
Post-exposure prophylaxis vaccination will be provided for individuals with identified close contact to a MPV case. Clinicians may request vaccine at monkeypoxPEP@cityofchicago.org
Additionally, vaccination is available in select clinical and community settings for those who are gay, bisexual, or other man who have sex with men and/or transgender, gender non-conforming, or gender non-binary who have intimate contact in a social or sexual venue, multiple or anonymous sexual partners, or give or receive money or goods in exchange for sex.

Please see the attachments for more information.

Menu Display

Search Bar